血清BNP TFC CO Scr水平与收缩功能障碍性心力衰竭患者短期预后关系研究

doi:10.3969/j.issn.1006-6233.2024.07.026

Abstract
Figure/Table
References
Related Citation (2)

Download: PDF (1137 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the relationship between serum BNP, TFC, CO, Scr and the short-term prognosis of patients with systolic dysfunction heart failure. Methods: A total of 93 patients with systolic dysfunction (LVEF<50%) heart failure admitted to the cardiovascular Department of Chengde Central Hospital from November 2021 to January 2023 were selected. Exacerbation of signs and symptoms of heart failure, cardiovascular re-visits and/or re-hospitalization, and cardiac death were recorded within 90 days after discharge. They were divided into two groups according to the prognosis: good prognosis group and bad prognosis group. Results: A total of 93 patients were followed up, 31 of whom had poor prognosis. LVEF, CO and the prevalence of coronary atherosclerotic heart disease in the poor prognosis group was lower than that in the good prognosis group, and the difference was statistically significant (P<0.05). BNP, cTnI, TFC and Scr in the poor prognosis group were higher than those in the good prognosis group, and the difference was statistically significant (P<0.05). Among them, BNP,TFC, CO and Scr are the factors influencing the adverse prognosis of patients with systolic dysfunction heart failure within 90 days after discharge(P<0.05). Conclusion: Volume load evaluation indexes BNP,TFC, CO and Scr are influential factors for the short-term prognosis of patients with systolic dysfunction heart failure, and may have a predictive effect on their prognosis, and have guiding significance for clinical treatment of patients with heart failure.

Key words： Systolic heart failure Cardiac output Serum creatinine Short-term prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2024.07.026 OR http://www.hbyxzzs.cn/EN/Y2024/V30/I7/1197

[1] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.
[2] Hao G,Wang X,Chen Z,et al.Prevalence of heart failure and left ventricular dysfunction in China:the China Hypertension Survey,2012-2015[J].European Journal of Heart Failure,2019,21(11):1329-1337.
[3] Wang H,Chai K,Du M,et al.Prevalence and incidence of heart failure among urban patients in China:a national population-based analysis[J].Circulation:Heart Failure,2021,14(10):8406.
[4] 杨旭希,郑吉洋,陈秀梅,等.慢性心力衰竭患者容量管理护理专家共识[J].中华介入放射学电子杂志,2023,11(3):201-207.
[5] 中华医学会急诊医学分会,北京医学教育协会急诊医学专科分会.生物电阻抗法无创血流动力学监测在急危重症应用的急诊专家共识[J].中华急诊医学杂志,2023,32(9):1163-1171.
[6] Vallabhajosyula S,Shankar A,Patlolla SH,et al.Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock[J].ESC Heart Failure,2020,7(3):1234-1245.
[7] Heidenreich PA,Bozkurt B,Aguilar D,et al.2022 AHA/ACC/HFSA guideline for the management of heart failure:executive summary:a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J].Journal of the American College of Cardiology,2022,79(17):1757-1780.
[8] Metra M,Tomasoni D,Adamo M,et al.Worsening of chronic heart failure:definition,epidemiology,management and prevention.A clinical consensus statement by the heart failure association of the european society of cardiology[J].European Journal of Heart Failure,2023,25(6):776-791.
[9] 陈希瑶,张富洋.心力衰竭易损期的定义与药物治疗[J].心脏杂志,2022,34(3):348-351.
[10] Chioncel O,Mebazaa A,Maggioni A P,et al.Acute heart failure congestion and perfusion status-impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry[J].European Journal of Heart Failure,2019,21(11):1338-1352.
[11] Heidenreich PA,Bozkurt B,Aguilar D,et al.2022 AHA/ACC/HFSA guideline for the management of heart failure:executive summary:a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines[J].ournal of the American College of Cardiology,2022,79(17):1757-1780.
[12] Vallabha josyula S,Shankar A,Patlolla SH,et al.Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock[J].ESC Heart Failure,2020,7(3):1234-1245.
[13] Zhu Y,Peng X,Wu M,et al.Risk factors of short-term,intermediate-term,and long-term cardiac events in patients hospitalized for HFmrEF[J].ESC Heart Failure,2022,9(5):3124-3138.
[14] 中国医师协会检验医师分会心血管专家委员会.B型利钠肽及N末端B型利钠肽前体实验室检测与临床应用中国专家共识[J].中华医学杂志,2022,102(35):2738-2754.